Candela receives U.S. FDA clearance of 595 nm pulsed-dye aesthetic laser

July 18, 2018
With the addition of a 1064 nm wavelength and other new features, the aesthetic laser will be able to effectively treat a broad range of skin conditions.

Aesthetic laser maker Candela (Wayland, MA) has received U.S. FDA clearance of its Vbeam Prima 595 nm pulsed dye laser (PDL). With the addition of a 1064 nm wavelength and other new features, the laser will be able to effectively treat a broad range of skin conditions, including rosacea; port wine stains; acne; facial, leg, and spider veins; scars; benign pigmented lesions; wrinkles; warts; stretch marks; and photoaging.

Related: Looking good with lasers

"In a clinical study using Vbeam Prima, facial redness and rosacea symptoms were dramatically reduced after four treatments," says Eric Bernstein, MD, M.S.E., Director of Laser Surgery & Cosmetic Dermatology at the Main Line Center for Laser Surgery (Ardmore, PA), an investigational site for the device. The laser offers 50% greater power to enable a 15 mm spot size, both contact and spray cooling, once-a-day calibration, and extended dye life, he adds.

For more information, please visit syneron-candela.com/na/prima.

About the Author

BioOptics World Editors

We edited the content of this article, which was contributed by outside sources, to fit our style and substance requirements. (Editor’s Note: BioOptics World has folded as a brand and is now part of Laser Focus World, effective in 2022.)

Voice your opinion!

To join the conversation, and become an exclusive member of Laser Focus World, create an account today!